GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (FRA:65G) » Definitions » Price-to-Operating-Cash-Flow

NextCell Pharma AB (FRA:65G) Price-to-Operating-Cash-Flow : (As of Jun. 02, 2025)


View and export this data going back to 2020. Start your Free Trial

What is NextCell Pharma AB Price-to-Operating-Cash-Flow?

As of today (2025-06-02), NextCell Pharma AB's share price is €0.077. NextCell Pharma AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2025 was €-0.06. Hence, NextCell Pharma AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for NextCell Pharma AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:65G's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 24.135
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

NextCell Pharma AB's Cash Flow from Operations per share for the three months ended in Feb. 2025 was €-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2025 was €-0.06.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 4.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -2.30% per year.

During the past 10 years, NextCell Pharma AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 20.70% per year. The lowest was -26.70% per year. And the median was 4.10% per year.


NextCell Pharma AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for NextCell Pharma AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Price-to-Operating-Cash-Flow Chart

NextCell Pharma AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NextCell Pharma AB Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NextCell Pharma AB's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, NextCell Pharma AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NextCell Pharma AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NextCell Pharma AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where NextCell Pharma AB's Price-to-Operating-Cash-Flow falls into.


;
;

NextCell Pharma AB Price-to-Operating-Cash-Flow Calculation

NextCell Pharma AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.077/-0.056
=

NextCell Pharma AB's Share Price of today is €0.077.
NextCell Pharma AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

NextCell Pharma AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


NextCell Pharma AB Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB Headlines

No Headlines